​

Funding Round

Post-IPO Debt - Delcath Systems

Post-IPO Debt - Delcath Systems

Investment Firm

Overview

Delcath Systems is an interventional oncology company that focuses on the treatment of metastatic liver cancer.

Announced Date

Apr 23, 2012

Funding Type

Post Ipo Debt

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

Silicon Valley Bank

Silicon Valley Bank

Silicon Valley Bank is a debt and early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

1

Investor Name
Participant InvestorSilicon Valley Bank

Round Details and Background

Delcath Systems raised $20000000 on 2012-04-23 in Post-IPO Debt

Delcath Systems is an interventional oncology company that focuses on the treatment of metastatic liver cancer.

Company Funding History

13

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 01, 2023
Post-IPO Equity - Delcath Systems
-35.0M
Mar 15, 2024
Post-IPO Equity - Delcath Systems
-7.0M
Jul 06, 2017
Post-IPO Equity - Delcath Systems
-2.0M
Jun 07, 2016
Convertible Note - Delcath Systems
-35.0M

Recent Activity

There is no recent news or activity for this profile.